EVISA Glossary on | Contact EVISA | Sitemap | Home   
 Advanced search
The establishment of EVISA is funded by the EU through the Fifth Framework Programme (G7RT- CT- 2002- 05112).


Supporters of EVISA includes:



Anti-cancer Agents in Medicinal Chemistry


 

Status
active
Indexing
Chemical Abstracts, BIOSIS, BIOSIS Reviews Reports and Meetings, BIOBASE, EMBASE, MEDLINE, BIOSIS Previews, Google, Google Scholar, Science Citation Index Expanded, Journal Citation Reports/Science Edition, Genamics JournalSeek, Scopus
Successor
Current Medicinal Chemistry - Anti-Cancer Agents
Subject

Source type
Journal
Publisher
ISBN ISSN
1871-5206
First volume
1
Last volume
9+
Homepage
Description

Anti-Cancer Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of new anti-cancer agents.

Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics in cancer medicinal chemistry.

Anti-Cancer Agents in Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments in cancer drug discovery.



Related links:









Imprint     Disclaimer

© 2003 - 2024 by European Virtual Institute for Speciation Analysis ( EVISA )